Abstract MPTU19: Gut Microbiota, Plasma Hippuric Acid, Fiber Intake, and Cardiometabolic Health in U.S. Populations.

Abstract

Introduction: Hippuric acid is a gut microbiota-derived metabolite of polyphenols. Few population studies have characterized human gut microbial features related to this metabolite. Hypothesis: To identify gut microbial species associated with plasma hippuric acid levels, investigate the relationships between diet, gut microbiota composition, and hippuric acid, and explore the prospective associations of circulating hippuric acid with the risks of type 2 diabetes (T2D), cardiovascular disease (CVD), and weight gain (WG) through a systematic, integrated approach. Methods: We included 287 men from Men's Lifestyle Validation Study (MLVS) with plasma metabolomics, fecal metagenomic data, and 7-day diet records. Findings were replicated in 207 women from Mind Body Study (MBS), 1833 women from Microbiome Among Nurses (MICRO-N), and 3,035 men and women from the Hispanic Community Health Study/Study of Latinos Gut Origins of Latino Diabetes (GOLD). Prospective associations between hippuric acid concentrations and risks of T2D, CVD, and WG were examined in 5,472 participants from the Nurses' Health Study (NHS), NHSII, and HPFS. Results: We identified 26 microbial species significantly associated with plasma hippuric acid, mainly from Lachnospiraceae and Oscillospiraceae families. A gut microbiome (GMB) species score developed in MLVS was strongly correlated with hippuric acid (Pearson r =0.73), replicating in MBS ( r =0.29) and GOLD ( r =0.14). Dietary fiber correlated with hippuric acid ( r =0.35) and 68% of this relationship was mediated by hippuric acid–associated bacteria, primarily fiber-fermenting Firmicutes . The GMB score was inversely associated with prevalent T2D (per SD: OR = 0.97, 0.95–0.99) in GOLD, and incident T2D (0.80, 0.66–1.00) and WG (-0.17 kg/2 years) in MICRO-N. In NHS and HPFS, higher plasma hippuric acid was associated with lower incident T2D risk (Q5 vs. Q1: HR = 0.77, 0.64–0.94) and slower BMI gain (β=-0.01 per SD). No association with CVD was observed. Conclusions: Our findings confirm gut microbiota's essential role in hippuric acid production in humans, and highlight its potential role in mediating the relationship between dietary fiber and plasma hippuric acid. Overall these data elucidate novel pathways partially underlying the health benefits of fiber intake on improving cardiometabolic health. Further studies are needed to clarify how fiber facilitates the hippuric acid production via interactions with polyphenol intake and the gut microbiome.